These findings suggest that higher SMPD3 expression may be linked with more favorable tumor characteristics, such as smaller size, lack of portal vein invasion, and earlier TNM stage, therefore supporting the potential role of SMPD3 as a beneficial factor in HCC progression and underscoring the need for further investigation into its clinical implications in HCC. The gene discussed is SMPD3; the disease is hepatocellular carcinoma.